Pulse electromagnetic field for treating postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials

Shuang Lang, Jianxiong Ma, Yan Wang, Shuwei Gong, Hengting Chen, Xinlong Ma2021 · DOI

Abstract

The aim of this meta-analysis of randomized controlled trials is to evaluate the efficacy and safety of Pulsed Electromagnetic Field (PEMF) therapy in the treatment of postmenopausal osteoporosis. Two authors independently searched four Chinese databases (CNKI, CBM, Wanfang, and VIP) and four English databases (Web of Science, PubMed, Cochrane Library, and Embase) from inception to September 10, 2021. The WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) were also consulted to identify potentially eligible studies. This protocol outlines a rigorous methodology for synthesizing global evidence to determine if PEMF can serve as a viable, non-invasive alternative to traditional pharmacological treatments.

Introduction: Addressing the Osteoporosis Crisis

Postmenopausal osteoporosis is a significant global health challenge, currently affecting approximately 200 million individuals. The condition arises when declining estrogen levels cause bone resorption to outpace bone formation, leading to increased skeletal fragility and life-threatening fractures. While pharmacological interventions like bisphosphonates and hormone replacement therapies are effective, they often require long-term commitment and carry risks of serious adverse effects, such as deep vein thrombosis and certain cancers.

Pulsed Electromagnetic Field (PEMF) therapy represents a non-invasive "biophysical" alternative designed to stimulate bone growth. Although PEMF is FDA-approved for specific clinical applications, its efficacy and safety profile for postmenopausal osteoporosis remain a subject of debate. This systematic review addresses the need for a standardized, high-quality synthesis of existing clinical data to move PEMF from a promising alternative to an evidence-based clinical recommendation.

Methodology and Study Protocol

As a study protocol, this document defines the analytical pipeline for the upcoming meta-analysis. The research team is conducting a comprehensive search across eight major databases to capture a globally representative sample of randomized controlled trials (RCTs).

Inclusion Criteria and Screening

The review is strictly limited to Parallel-group Randomized Controlled Trials (RCTs) to ensure the highest level of evidence. Two independent reviewers perform the screening process, with a third reviewer acting as an arbitrator for any discrepancies.

Statistical Analysis and Bias Control

Data synthesis will utilize either fixed-effect or random-effect models based on the level of heterogeneity ($I^2$ statistic). If $I^2 > 50\%$, a random-effect model will be employed to account for variance between studies. The Cochrane "risk of bias" tool will be used to evaluate study quality across seven key domains, including randomization, blinding, and selective reporting.

Outcome Measures

The primary outcomes of interest include:

  • Bone Mineral Density (BMD): Specifically at the lumbar vertebra, femur, and Ward’s triangle.
  • Safety Profile: A rigorous analysis of Adverse Events (AEs) using Risk Ratios (RR).
  • Pain Management: Evaluation of changes in Visual Analogue Scale (VAS) scores.

Discussion: Bridging the Evidence Gap

A key strength of this protocol is its inclusion of major Chinese databases. Much of the existing research on PEMF and physical therapies is published in Chinese literature, which is frequently overlooked in Western meta-analyses. By bridging this "East-West" data gap, the study aims for a more comprehensive and globally representative conclusion.

Furthermore, the analysis goes beyond simple BMD measurements. By tracking biochemical markers (such as ALP and Osteocalcin) alongside patient-reported pain, the researchers can assess the holistic impact of PEMF on quality of life. The planned use of meta-regression will also help identify optimal treatment parameters, such as frequency and duration, potentially establishing a "gold standard" for PEMF application in clinical settings.

Limitations and Future Outlook

The primary challenge lies in the inherent heterogeneity of PEMF devices; different frequencies and intensities may yield varying results. While subgroup analyses are planned, the lack of standardized "dosing" remains a hurdle. Additionally, despite the dual-language search, language bias may persist if relevant trials in other languages (e.g., German or Japanese) are excluded.

Once completed, this meta-analysis will serve as a foundational resource for clinical guidelines, potentially establishing PEMF as a key non-pharmacological intervention for bone health management in postmenopausal women.

Summary updated

Abstract

Review question / Objective: The aim of this meta-analysis of randomized controlled trials is to evaluate the efficacy and safety of PEMF in the treatment of postmenopausal osteoporosis. I n f o r m a t i o n s o u rc e s : Tw o a u t h o r s ( S L a n d S W G ) independently searched 4 Chinese databases (China National Knowledge Infrastructure (CNKI), Chinese BioMedical (CBM) Literature Database, Wanfang, and VIP) and 4 English databases (Web of Science, PubMed, Cochrane Library, and Embase) from inception to September 10, 2021 to acquire potentially eligible studies. WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) were checked to identify the studies with potential composite inclusion criteria. The detailed search strategy for each database is provided in SupplementaryMaterials.
BibTeX
@misc{lang2021pulse,
  author = {Shuang Lang and Jianxiong Ma and Yan Wang and Shuwei Gong and Hengting Chen and Xinlong Ma},
  title = {{Pulse electromagnetic field for treating postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials}},
  year = {2021},
  doi = {10.37766/inplasy2021.11.0066},
}
Figure